TrialHuman vaccines & immunotherapeutics2017

Randomized, double-blind, multi-center, phase III clinical trial to evaluate the immunogenicity and safety of MG1109 (egg-based pre-pandemic influenza A/H5N1 vaccine) in healthy adults.

Joon Young Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.